Brain aging is accompanied by increased oxidative stress and what has been termed "neuroinflammation," which might contribute to age-related neurodegenerative diseases. We analyzed expression in the transcription of innate inflammatory response genes in eleven representative regions including frontal, parietal, inferior temporal, cingulate, occipital, entorhinal cortex, caudate, putamen, thalamus, substantia nigra, and cerebellar vermis in aging human brains. We probed members of the complement system, colony stimulating factor receptors, toll-like receptors, and pro-and anti-inflammatory cytokines in the brains of subjects with no neurological disease and neurofibrillary tangles (mean age: 47.1 6 5.7 years) and those with no neurological disease and neurofibrillary pathology stages I-II (mean age: 70.6 6 6.3 years). Although the entorhinal and frontal cortex were most altered, gene regulation patterns did not match regions with increased vulnerability. Analysis of false discovery rate thresholds revealed no differences for any gene in any region between the 2 groups, including cases in which individual comparisons analyzed using Student t or nonparametric tests showed apparent differences between groups. Moreover, gene expression of major antioxidative stress responses did not match neuroinflammation in aging or increased regional susceptibility to major neurodegenerative diseases.
INTRODUCTION
Aging in the human brain is linked to a low level of neuroinflammation, which is manifested by responses in microglia and astrocytes and in the expression of cytokines and mediators of the innate immune response (1) (2) (3) (4) (5) (6) . Aged microglial cells in rodents show accumulation of lipofuscin, variation in size, elongation of the cytoplasm, and shortening of ramifications (7, 8) . Microglial cells in humans also show accumulation of lipofuscin, retraction of dendritic branches, and rounded cytoplasm. The most extreme modification of microglia in human brain is loss of dendrites, increased tortuosity of processes, cytoplasm beading, and fragmentation consistent with cytorrhexis (9, 10) . Senescent microglia in rodents show increased expression of major histocompatibility complex II, CD11, and pro-inflammatory cytokines (11) (12) (13) (14) . Furthermore, transcriptome characterization of fluorescence activated cell sorting (FACS)-isolated cortical microglia from young and aged mice confirms increased expression of interleukins (48) and of gene ontology classes corresponding to cytokine activity and regulation of lymphocyte activation but also reduced inflammatory response in aged vs young microglia (15) . Increased expression of inflammatory cytokines is detected in aged microglia in human brains (16) .
Aging astrocytes accumulate lipofuscin and cytoplasmic filaments and show increased glial fibrillary acidic protein (GFAP) and vimentin content, as well as morphological changes in the nucleus and cytoplasm (18) (19) (20) (21) (22) . Changes in astrocytes depend on the cell type and brain region (21, 23, 24) . Expression of cytokines is also increased in aged astrocytes (25, 26) . Hippocampal astrocytes from aged adult rats have increased expression of several cytokines (16, (27) (28) (29) (30) . Transcriptome studies of cortical FACSisolated astrocytes from young and aged mice show increased gene ontology class corresponding to antigen processing and presentation (53) .
Upregulation of cytokines and mediators of inflammation occurs in the brains of mice and in human aging, with marked interspecies differences (31, 32) . Upregulation of innate inflammatory responses occurs in human neurodegenerative diseases with abnormal protein aggregates. It has been suggested that there is an overlap between normal aging and Alzheimer disease (AD) genes (33) . However, inflammation in neurodegenerative diseases in human and corresponding animal models is not a mere intensification of neuroinflammation in normal aging because gene expression responses are disease-, stage-and region-dependent (31, 32, (34) (35) (36) .
The first objective of the present study was to assess whether regional differences in innate inflammatory responses occur in normal human brain aging, in line with our previous observations showing regional variations in gene expression in neurodegenerative diseases with abnormal protein aggregates. The second objective was to examine whether regional differences, if present, were predictors of selective regional vulnerability to common neurodegenerative diseases in old age, with a particular focus on AD and Parkinson disease (PD). Human postmortem brains of individuals with no clinical or brain lesions were analyzed in comparison to individuals with no clinical neurological manifestations but with neurofibrillary pathology stages I-II. Because stages I-II occur in approximately 85% of individuals aged 65 (37, 38) , the selection of individuals with stages I-II of neurofibrillary pathology was considered a change compatible with normal brain aging. Patients with putative confounding factors such as systemic inflammation and immune disorders and combined pathologies in the brain were excluded to obtain a relatively homogeneous population. Twenty-two genes in 11 regions were assessed in 18 individuals divided into 2 groups. The selection of genes was based on the fact that the same genes have been assessed in our previous studies of several neurodegenerative diseases with abnormal protein aggregates in aged brains (32, (34) (35) (36) , thus permitting subsequent analysis of commonalities and differences among neurodegenerative diseases. Selected regions were cerebral cortex (frontal, parietal, inferior temporal, occipital, cingulate, and entorhinal), striatum (caudate and putamen), thalamus, substantia nigra and cerebellar vermis, all of which are differentially vulnerable to neurodegenerative diseases in elderly. Although little is known about the causes of glial activation in normal aging (39) , oxidative stress can mediate inflammation (29, 40) , and microglia and astrocytes are sensitive to oxidative stress (41, 42) . For this reason, the core study was accompanied by gene expression analysis of markers of oxidative stress responses.
MATERIALS AND METHODS

Human Brain Samples
Human brain samples were obtained from the Institute of Neuropathology Brain Bank (HUB-ICO-IDIBELL Biobank, Barcelona, Spain) following the guidelines of the Spanish legislation on this matter and the approval of the local ethics committee.
One hemisphere was immediately cut into 0.5-cm-thick coronal sections and selected areas of the encephalon were rapidly dissected, frozen on metal plates over dry ice, placed in individual air-tight plastic bags, numbered with waterresistant ink, and stored at À80 C. The other hemisphere was fixed by immersion in 4% buffered formalin for 3 weeks for morphological studies.
Neuropathological examination was carried out on 4-mm-thick, de-waxed paraffin sections from 20 selected regions, which were stained with hematoxylin and eosin, Klü-ver-Barrera, and processed for immunohistochemistry with antibodies to phosphorylated tau (clone AT8, diluted 1:50; Innogenetics, Ghent, Belgium), b-amyloid (diluted 1:50; Roche, Basel, Switzerland), a-synuclein (diluted 1:300; Chemicon, Merck-Millipore, Billerica, MA), TDP-43 (diluted 1:1,000, Abcam, Cambridge, UK), ubiquitin (diluted 1:200; Dako, Carpinteria, CA), GFAP (diluted 1:400; Dako), Iba-1 (diluted 1:1000; Wako, Tokyo, Japan), and CD68 (diluted 1:200; Abcam). Sections were subsequently rinsed in distilled water and incubated with biotinylated secondary antibody (Dako) followed by EnVision þ System peroxidase (Dako). The immunoreaction was visualized with diaminobenzidine and H 2 O 2 . Sections were lightly counterstained with hematoxylin, dehydrated, cover-slipped and examined under a Nikon Eclipse E800 microscope (Nikon Imaging, Inc., Tokyo, Japan). Control of immunostaining included omission of the primary antibody; no signal was obtained after incubation with only the secondary antibody.
For gene expression studies, samples from the following regions were used: frontal cortex area 8, parietal cortex area 7, inferior temporal cortex area 20, occipital cortex areas 17-18, cingulate gyrus area 24, entorhinal cortex, head of the caudate, anterior putamen, thalamus, substantia nigra and upper vermis. Samples were from individuals with no neurological histories and without focal or systemic infectious, inflammatory or autoimmune diseases. Cases with metabolic syndrome, disseminated malignant diseases or drug abuse, particularly ethanol consumption, were not included. Special care was also taken not to include cases with prolonged agonal state (patients subjected to intensive care or experiencing hypoxia).
After neuropathological examination, cases with neurodegenerative or vascular diseases were excluded, except those with Braak and Braak stages I-II of neurofibrillary tangle pathology. Cases with associated neurodegenerative processes (ie a-synucleinopathy, argyrophilic grain pathology, and TDP-43 proteinopathy) were excluded. Only cases with minor changes consistent with small blood vessel disease were used. Some cases had mild status cribrosus in the striatum with no apparent clinical implications. Cases with no neurofibrillary pathology (n ¼ 9; 7 men and 2 women) were 47.1 6 5.7 years old and had no clinical abnormalities or neuropathological lesions. Cases with stages I-II of neurofibrillary pathology (n ¼ 9; 7 men and 2 women) were 70.6 6 6.3 years old and had no clinical symptoms. b-amyloid deposition was absent in every case. A summary of cases and regions analyzed is shown in Table 1 .
RNA Isolation
Total RNA from 11 regions was isolated with RNeasy Lipid Tissue Mini Kit (Qiagen GmbH, Hilden, Germany) following the manufacturer's protocol. Afterward, samples were treated with Ambion DNA-free DNase for 30 minutes to avoid extraction and subsequent amplification of genomic DNA. RNA concentration of each sample was obtained from A260 measurements with Nanodrop 2000 (Thermo Scientific, Wilmington, DE). RNA integrity was tested using the Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA), and the threshold for sample selection was set equal to or higher than 5. 
Retrotranscription Reaction
Retrotranscription reaction was carried out using a High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA) following the instructions provided by the supplier. Parallel reactions were carried out in the absence of reverse transcriptase to verify absence of DNA contamination.
TaqMan RT-qPCR
TaqMan RT-qPCR assays for each gene were carried out in duplicate on cDNA samples in 384-well optical plates using an ABI Prism 7900 Sequence Detection system (Applied Biosystems, Life Technologies, Waltham, MA). For each 10 lL TaqMan reaction, 4.5 lL cDNA was mixed with 0.5 lL 20Â TaqMan Gene Expression Assays and 5 lL of 2Â TaqMan Universal PCR Master Mix (Applied Biosystems).
Parallel assays for each sample were analyzed simultaneously for internal control, using hypoxanthine-guanine phosphoribosyltransferase (HPRT) and b-glucuronidase (GUSB) for normalization (43, 44) . The reactions were performed using the following parameters: 50 C for 2 minutes, 95 C for 10 minutes, 40 cycles of 95 C for 15 seconds, and 60 C for 1 minute. Finally, TaqMan RT-qPCR data were captured using the Sequence Detection Software (SDS version 2.2, Applied Biosystems). TaqMan probes used in this study are shown in Table 2 . Samples were analyzed with the double-delta cycle threshold (DDCT) method using middle-aged subjects as calibrator samples.
Statistics
The normality of distribution of fold change values was analyzed with the Kolmogorov-Smirnov test. The nonparametric Mann-Whitney test was performed to compare each group when values did not follow a normal distribution, while the unpaired t-test was used for normal variables. Statistical analysis was performed with GraphPad Prism version 5.01 (La Jolla, CA). The data were expressed as mean 6 SE; significance levels were set at *p < 0.05 and **p < 0.01.
However, because of the large number of parameters and regions analyzed, multiple comparison tests were mandatory in the present context. Adjustments based on study-wide error rate such as Bonferroni and Sidak corrections have been considered to be too conservative and with low statistical power (45) . Therefore, the false discovery rate (FDR) was employed using a maximum discovery rate of 5% (46, 47) . Steps were as follows: all p values were classified and ranked in an ascending order; Benjamini-Hochberg critical value was estimated for each p value:
p values below the largest p value equal or lower than BH i were considered statistically significant.
RESULTS
General Neuropathological Findings
According to the selection conditions for the cases in this series, the most important difference between the 2 groups was the presence of neurofibrillary pathology stages I-II of Braak and Braak. As expected, neurofibrillary tangles were found in the entorhinal and transentorhinal cortices; the remaining assessed brain regions were devoid of tau pathology. b-amyloid and deposits of other abnormal proteins were GUSB and HPRT were used for normalization.
absent. Small blood vessel disease was more common, and status cribrosus was more frequent with age.
Gene Expression of Cytokines and Mediators of the Immune Response
The expression of 18 genes, including members of the complement system (C1QL1, C1QTNF7, and C3AR1), colony stimulating factor receptors (CSF1R and CSF3R), Toll-like receptors (TLR4 and TLR7), pro-inflammatory cytokines and receptors (IL1B, IL8, IL6, IL6ST, TNF, and TNFRSF1A), and anti-inflammatory cytokines and receptors (IL10, IL10RA, IL10RB, TGB1, and TGB2) was assessed. The selection of these particular genes was based on the fact that they have been analyzed in several human neurodegenerative diseases in old age; therefore, comparative analyses could be made regarding diseases, regions, and stages of the different processes (31, 32, (34) (35) (36) .
The most prevalent gene expression modification in the majority of regions was increased TLR7 and IL1B expression levels in cases with neurofibrillary pathology stages I-II when compared with cases with no neurofibrillary degeneration. Increased expression of TLR7 was found in frontal cortex, temporal cortex, occipital cortex, entorhinal cortex, caudate, putamen, and vermis, whereas IL1B mRNA expression was increased in frontal cortex, occipital cortex, entorhinal cortex, putamen, thalamus, and vermis.
The most affected region was the entorhinal cortex, as the expression of C3AR1, CSF3R, TLR7, IL1B, IL6, and IL10 mRNAs was apparently increased in cases with neurofibrillary pathology. This was followed by frontal cortex area 8 in which IL6 and IL10RB expression was increased in addition to TLR7 and IL1B.
Three regions showed particular patterns due to the combination of increased and decreased expression of individual genes in the group with neurofibrillary pathology stages I-II. Increased TNFRSF1A, and decreased C1QL1, IL10RA, and IL10RB, occurred in the putamen. Increased C3AR1 and IL1B mRNA expression, together with reduced IL8, IL6, and IL6ST expression, was found in the thalamus. Increased CSFR3, TLR7, IL1B, and TNF, and reduced IL8, IL6, IL10RA and IL10RB, was observed in the upper vermis.
Interestingly, no differences in gene expression between the 2 groups were seen in the cingulate cortex or substantia nigra. Results of gene expression in all regions are shown in Table 3 .
Gene Expression of Glial Cell Markers and Markers of the Oxidative Stress Response
GFAP mRNA expression levels were increased in the frontal cortex, inferior temporal cortex, and caudate. AIF-1 (which encodes Iba-1) was upregulated in the caudate and CD68 in the thalamus. COX2 was downregulated in all regions. PTGDS was upregulated in the parietal cortex, SOD2 mRNA was upregulated in the caudate and downregulated in putamen, and SOD1 was downregulated in parietal cortex and putamen. CAT (which encodes catalase) mRNA expression levels was not modified with age in any region (Table 4) .
Multiple Comparison Analysis and False Discovery Rate Thresholds
P values for every gene in the 11 regions when comparing the 2 groups of cases are shown in Table 5 . FDR thresholds revealed no significant differences in any case, including those genes in which individual analysis using nonparametric and t-test depending on normal distribution, revealed apparent significant differences in their expression levels (Table 5) .
DISCUSSION
In healthy aged humans, in vivo positron emission tomography using R-[11C]PK11195 reveals increased ligand binding in several cortical and subcortical areas, indicating increased levels of basal microglial activation (48) . This is accompanied by modifications in the morphology of microglia, which reflect a senescent phenotype (9, 10, 17, 49); GFAP-immunoreactive astrocytes increase in old age (18, 19, 21, 22 ).
The present study shows that the entorhinal cortex is the region with the greatest increase of cytokines and mediators of the inflammatory response, followed by the frontal cortex. Thalamus, putamen and, to a lesser extent, caudate showed a combination of increased and decreased expression of individual genes, whereas the cingulate cortex and substantia nigra do not show modifications in the expression of the assessed genes. In contrast, the upper cerebellar vermis is a region in which cytokines and mediators of inflammation are, apparently, highly modulated with age.
The most prevalent genes with increased mRNA expression are TLR7 and IL1B. The expression of C3AR1, CSF3R, IL6, and IL10RB mRNAs is increased, in addition, in the entorhinal cortex, whereas IL6 and IL10RB are also increased in frontal cortex. Caudate, putamen, and thalamus show a combination of increase and decrease inboth pro-inflammatory and anti-inflammatory cytokines and mediators. Tlr7 and Il1B are upregulated in the aged mouse somatosensory cortex (31, 32, 36, 50) . IL-1b and IL-6 expression increases in rat cortex with aging (25, 30) .
The present findings in the entorhinal and frontal cortex are in line with those published in other series (32) . That series included entorhinal cortex area 28 (11 cases with neurofibrillary pathology stages I-II and 7 cases with no neurofibrillary tangles) and frontal cortex area 8 (11 cases with neurofibrillary pathology and 15 cases with no neurofibrillary pathology) (32) . TLR7, IL1B C3AR1, CSF3R, and IL6 were upregulated in the entorhinal cortex, and TLR7, IL1B, and IL6 were upregulated in the frontal cortex (32) .
Toll-like receptor signaling is activated by RNA of multiple viruses and bacteria and products of damaged neurons; this signaling can initiate innate immune responses after brain exposure to several sources of stress (51) (52) (53) (54) (55) . Microglia are strongly activated by TLR agonists (56, 57) . IL-6 in the nervous system acts mainly as a neurotrophic factor in normal conditions and in several experimental models, although it can also play a role as a pro-inflammatory cytokine (58) .
Toll-like receptors are mainly expressed in microglia (57), whereas IL-1b and IL-6 are mainly localized in astrocytes (25) ; however, IL-6 is also expressed in microglia (32) . IL1-b increases in astrocytes after lipopolysaccharide exposure in aged rats (59), but IL-1b-immunoreactive structures are also detected near the astrocytes and microglia in old diabetic rats (20) . Moreover, IL-1b can be produced by microglia in vitro under particular settings (60) . The action of cytokines and chemokines is complex and depends on the environment and particular settings (61, 62) . Therefore, it is difficult to interpret the functional (or putatively pathogenic) implications of regional neuroinflammatory modulation in the aging human brain. Moreover, due to the different types of astrocytes in human brain (63, 64) , the identification of responses, including expression of inflammatory mediators in particular types of aged astrocytes, is in its infancy.
Considering the categories of molecules linked to innate inflammatory response regulated in brain aging, the message from the present study is not clear because both proinflammatory and anti-inflammatory cytokines are increased or decreased in several regions. This pattern seems to argue in favor of disorganized inflammatory gene transcription in the aged brain rather than a stereotyped inflammatory response to a particular stimulus.
GFAP mRNA levels increase with age in human, rat, and mouse brain (65, 66) . However, significant differences between cases with no neurofibrillary pathology and those with neurofibrillary pathology were observed in the frontal and temporal cortices and caudate, although a trend toward increase was seen in other regions except the occipital cortex, entorhinal cortex, and thalamus. The expression levels of AIF-1 mRNA were unexpected because an increase was only detected in 1 region, despite augmented Iba-1 immunoreactivity in aged individuals.
It is known that mRNA expression levels may not match protein levels because translation is regulated by several factors including small and large noncoding RNAs. However, it is worth stressing at this point that region-dependent gene modulation of cytokines and mediators of the innate response in aging do not match mRNA expression of astrocyte and microglia cell markers.
Cyclooxygenases 1 and 2 (COX-1 and COX-2) convert arachidonic acid to prostaglandin H2 and participate in inflammation. In the brain, COX-1 is mainly localized in microglia (67), whereas COX-2 is localized in neurons and synapses (68) . Hippocampal astrocytes in culture from aged rats exhibit increased expression of inflammatory markers including COX-2 (27) . Moreover, increased mRNA levels of COX-2 are observed in cultured aged astrocytes (27) . The COX2 mRNA downregulation observed here in the aged human brains is difficult to explain as it coexists with a complex reaction of up-and downregulation of pro-inflammatory and anti-inflammatory cytokines in several brain regions. There remains the possibility that increased COX2 protein levels occur despite decreased COX2 mRNA regulation with aging. Cyclopentenone prostaglandins have anti-inflammatory activity and some of them can act as modulators of COX2 activity (69) . Prostaglandin D2 synthase, encoded by PTGDS, catalyzes the conversion of prostaglandin H2 to prostaglandin D2. Prostaglandin D2 functions as a neuromodulator as well as a trophic factor in the central nervous system.
Microglial activation and neuroinflammatory responses are currently observed in most neurodegenerative diseases in the elderly, and they are determinants in the pathogenesis of these processes (36, (70) (71) (72) . Senescent microglia are associated with increased susceptibility of the aged CNS to neurodegeneration (42, 73) . Astrocytes participate in the maintenance of blood-brain barrier, and astrocyte senescence has deleterious effects on its barrier function, calcium homeostasis, and expression of flux transporters Cases in which individual comparisons showed apparent significant differences between groups. FDR, false discovery rate. (74) (75) (76) (77) (78) (79) . Senescent astrocytes in vitro show decreased neuroprotective capacity (80) . Regional expression patterns of the genes involved in innate inflammatory responses in the present study did not fit with increased vulnerability to any particular neurodegenerative disease in aging, except the entorhinal cortex, which showed increased expression of several cytokines and mediators of the innate inflammatory response in the older group. This was not unexpected because the older individuals studied were affected by neurofibrillary pathology stages I-II. However, no other relationship could be established between innate inflammatory responses and regional vulnerability in other brain regions affected in AD. Curiously, no changes are observed in the substantia nigra with age, which is in contrast with the reduced gene transcription of the same genes in the substantia nigra at early stages of PD (19) . Considering the striatum and cerebellum along with other brain regions, it is also difficult to establish a relationship between neuroinflammation with brain aging and regional vulnerability to Huntington disease and spinocerebellar atrophies, respectively.
Finally, as a preliminary observation, gene regulation of the innate inflammatory response did not parallel gene regulation of typical anti-oxidative stress responses including SOD1, SOD2, and CAT. Increased SOD2 mRNA expression occurs in the caudate, but it is decreased in the putamen. Thus, it is not clear whether neuroinflammation and altered glial cell activation have any protective or deleterious effect in normal brain aging. The present findings, rather, fit with a scenario in which regional inflammation in aging is not a predisposing factor of major susceptibility to any particular neurodegenerative disease.
Certain parameters were significantly different between the 2 groups when using the nonparametric Mann-Whitney test for data that did not follow a normal distribution and the unpaired t-test for normal variables. Significances were lost when applying more restrictive statistical methods. Here, 26 parameters were compared between 2 groups in 11 brain regions resulting in a total of 284 comparisons (data were not available for PTGDS in putamen and vermis). Hence, the probability that at least 1 test would be incorrectly rejected if all test were independent was 99.99% (obtained from 1- (1-a) k where k is the number of comparisons and a the error type I). For every region, the probability that at least 1 test would be incorrectly rejected was 74%. For every analytical data, the probability that at least 1 test would be incorrectly rejected was 43%. After applying the FDR (45) (46) (47) , no value was statistically significant.
The marked discrepancies when analyzing individual comparisons of multiple data and multiple comparisons corrected by FDRs are important at the time of the interpretation of data. It is possible that significant results are obtained with fewer comparisons and larger samples.
Further studies are needed to assess brain regionspecific inflammation responses in old age with other putative parameters such as regional specificities related to lipid and fatty acid composition, oxidative stress and oxidative stress responses, as well as region-specific metabolomes in aging.
